CompletedNot Applicable

Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD

France292 participantsStarted 2021-03-18

Plain-language summary

This study aims to examine the link between Non-Alcoholic Fatty Liver Disease (NAFLD) and cardiovascular diseases by studying the association between liver fibrosis degree and cardiovascular risk factors. The study would clarify the value and the role of the Coronary calcium score (CAC score) in the screening for coronary disease in this population at high cardiovascular risk.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * NAFLD patients regardless of disease stage of severity (from simple steatosis to cirrhosis) * Patient without known heart disease * Patient agreeing to participate and who has given his non opposition Exclusion Criteria: * Association with another cause of liver disease * Already known coronary artery disease * Pregnancy or breastfeeding in progress

What they're measuring

Coronary calcium score

Timeframe: At inclusion

Shear wave liver elastography

Timeframe: At inclusion

Trial details

NCT IDNCT04774302

SponsorClinique Pasteur

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-04-30

View on ClinicalTrials.gov More NAFLD trials